Secretory Mammary Carcinoma In Situ in a Cat
DOI:
https://doi.org/10.22456/1679-9216.142887Keywords:
feline, alpha-lactalbumin, mammary neoplasm, PAS, secretionAbstract
Background: Secretory carcinoma is a rare mammary neoplasm observed in humans and animals. It was 1st called juvenile carcinoma. Secretory carcinoma is characterized by eosinophilic secretory material, both intra- and extracellularly, and neoplastic cells with a signet ring appearance. It is usually invasive, with a few rare reports of its non-invasive form, secretory carcinoma in situ, in humans. In veterinary medicine, only 2 cases of secretory carcinoma have been reported, both in dogs. This case is the 1st report of secretory carcinoma in a cat and the 1st instance of secretory carcinoma in situ in veterinary medicine, highlighting its histopathological, histochemical and immunohistochemical features.
Case: A 15-year-old female mixed-breed cat was presented with multiple small nodules located in the right mammary chain. The cat underwent a mastectomy to remove the affected tissue. Upon histological examination of the cranial abdominal mammary gland (A1), a well-delimited neoplasm was identified. The tumor exhibited tubular and cluster formations of cells, with no evidence of invasion beyond the basal membrane. There was a significant deposition of both inter- and extracellular eosinophilic material, and the neoplastic cells showed prominent vacuolation, giving them a signet ring appearance. To further support the suspected diagnosis of secretory carcinoma, histochemical and immunohistochemical tests were conducted. Histochemical staining using Periodic Acid-Schiff (PAS), both with and without diastase digestion, revealed positive results for the neoplastic cells, indicating the presence of secretory material. Additionally, the cells tested positive for the alpha-lactalbumin antibody, further supporting the diagnosis of secretory carcinoma. The Ki67 proliferation index was measured at 30%, which is considered relatively high, indicating a notable degree of cell proliferation. Furthermore, immunohistochemical analysis confirmed the presence of myoepithelial cells surrounding the tubules and cell clusters, as demonstrated by the positivity for alpha-smooth muscle actin and p63. This confirmed the in situ nature of the neoplasm, as the absence of invasion was confirmed, leading to the definitive diagnosis of secretory carcinoma in situ. Unfortunately, no follow-up information was available regarding the cat's post-surgical condition.
Discussion: The diagnosis of secretory mammary carcinoma in animals can be made based on the characteristic morphology, which includes the presence of both intra- and extracellular eosinophilic secretion and the vacuolated, signet ring appearance of the neoplastic cells. Histochemical and immunohistochemical techniques are essential to confirm the diagnosis. PAS staining, with and without the diastase reaction, is useful in identifying the secretory material within the cells. Furthermore, the positivity for alpha-lactalbumin in both the cytoplasm of the neoplastic cells and the extracellular secretion helps corroborate the diagnosis. It is important to differentiate secretory carcinoma in situ from other tumor types with a similar morphology, given the potential for aggressive behavior associated with this neoplasm. However, in the present case, the prognosis is likely more favorable due to the absence of invasion and metastasis, as evidenced by the in situ nature of the tumor. More cases of secretory carcinoma and secretory carcinoma in situ need to be diagnosed and described in veterinary medicine to gain a better understanding of their biological behavior and prognosis.
Keywords: feline, alpha-lactalbumin, mammary neoplasm, PAS, secretion.
Downloads
References
Aktepe F., Sarsenov D. & Ozmen V. 2016. Secretory carcinoma of the breast. Journal of Breast Health. 12(4): 174-176. DOI: 10.5152/bs.2016.3249. DOI: https://doi.org/10.5152/bs.2016.3249
Banerjee N., Banerjee D. & Choudhary N. 2021. Secretory carcinoma of the breast commonly exhibits the features of low grade, triple negative breast carcinoma- A Case report with updated review of literature. Autopsy Case Reports. 11: 1-8. DOI: 10.4322/acr.2020.227. DOI: https://doi.org/10.4322/acr.2020.227
Bertagnolli A.C., Cassali G.D., Genelhu M.C.L.S., Costa F.A., Oliveira J.F.C. & Gonçalves P.B.D. 2009. Immunohistochemical expression of p63 and Δnp63 in mixed tumors of canine mammary glands and its relation with p53 expression. Veterinary Pathology. 46(3): 407-415. DOI: 10.1354/vp.08-VP-0128-C-FL. DOI: https://doi.org/10.1354/vp.08-VP-0128-C-FL
Burstein H.J., Polyak K., Wong J.S., Lester S.C. & Kaelin C.M. 2004. Ductal carcinoma in situ of the breast. The New England Journal of Medicine. 350(14): 1430-1441. DOI: 10.1056/NEJMra031301. DOI: https://doi.org/10.1056/NEJMra031301
Cassali G.D., Gobbi H., Gartner F. & Schmitt F.C. 1999. Secretory carcinoma of the canine mammary gland. Veterinary Pathology. 36(6): 601-603. DOI: 10.1354/vp.36-6-601. DOI: https://doi.org/10.1354/vp.36-6-601
Cassali G., Lavalle G.E., Ferreira E., Estrela-Lima A., Nardi A.B., Ghever C., Sobral R.A., Amorim R.L., Oliveira L.O. & Sueiro F.A.R. 2014. Consensus for the diagnosis, prognosis and treatment of canine mammary tumors. Brazilian Journal of Veterinary Pathology. 7(2): 38-69.
Cassali G.D. & Nakagaki K.Y.R. 2023. Neoplasias malignas. In: Cassali G.D., Ferreira E. & Campos C.B. (Eds). Patologia Mamária Canina Felina do Diagnóstico ao Tratamento. São Paulo: MedVet, pp.169-222.
Din N.U., Idrees R., Fatima S. & Kayani N. 2013. Secretory carcinoma of breast: clinicopathologic study of 8 cases. Annals of Diagnostic Pathology. 17(1): 54-57. DOI: 10.1016/j.anndiagpath.2012.06.001. DOI: https://doi.org/10.1016/j.anndiagpath.2012.06.001
Drilon A., Li G., Dogan S., Gounder M., Shen R., Arcila M., Wang L., Hyman D.M., Hechtman J., Wei G., Cam N.R., Christiansen J., Luo D., Maneval E.C., Bauer T., Patel M., Liu S.V., Ou S.H.I., Farago A., Shaw A., Shoemaker R.F.S., Lim J., Hornby Z., Multani P., Ladanyi M., Berger M., Katabi N., Ghossein R. & Ho A.L. 2016. What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC). Annais of Oncology. 27(5): 920-926. DOI: 10.1093/annonc/mdw042. DOI: https://doi.org/10.1093/annonc/mdw042
Ellis I.O., Schnitt S.J., Sastre-Garau X., Bussolati F.A., Eusebi V., Pertse J.L., Mukai K., Tabár L., Jacquemier J., Cornelisse C.J., Sasco A.J., Kaaks R., Pisani P., Goldgar D.E., Devilee P., Cleton-Jansen M.J., Borresen-Dale A.L., van’t Veer L. & Sapino A. 2003. Tumours of the Breast. In: Tavassoli F.A. & Devilee P. (Eds). Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press, pp.42-43.
Eusebi V., Ichihara S., Vincent-Salomon A., Sneige N. & Sapino A. 2012. Exceptionally rare types and variants. In: Lakhani S.R., Ellis I.O., Schnitt S.J., Tan P.H. & van de Vijver M.J. (Eds). WHO Classification of Tumours of the Breast. 4th edn. Lyon: IARC Press, pp.41-42.
Kameyama K., Mukai M., Iri H., Kuramochi S., Yamazaki K., Ikeda Y. & Kata J. 1998. Secretory carcinoma of the breast in a 51-year-old male. Pathology International. 48(12): 994-997. DOI: 10.1111/j.1440-1827.1998.tb03873.x. DOI: https://doi.org/10.1111/j.1440-1827.1998.tb03873.x
Krausz T., Jenkins D., Grontoft O., Pollock D.J. & Azzopardi J.G. 1989. Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis. Histopathology. 14(1): 25-36. DOI: 10.1111/j.1365-2559.1989.tb02111.x. DOI: https://doi.org/10.1111/j.1365-2559.1989.tb02111.x
Krings G., Chen Y.Y., Sorensen P.H.B. & Yang W.T. 2019. Secretory Carcinoma. In: WHO Classification of Tumours Editorial Board (Eds). WHO Classification of Tumours - Breast Tumours. 5th edn. Lyon: International Agency for Research on Cancer, pp.146-149.
Laé M., Fréneaux P., Sastre-Garau X., Chouchane O., Sigal-Zafrani B. & Vincent-Salomon A. 2009. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum. Modern Pathology. 22: 291-298. DOI:10.1038/modpathol.2008.184. DOI: https://doi.org/10.1038/modpathol.2008.184
Li D., Xiao X., Yang W., Shui R., Tu X., Lu H. & Shi D. 2012. Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature. Modern Pathology. 25(4): 567-575. DOI:10.1038/modpathol.2011.190. DOI: https://doi.org/10.1038/modpathol.2011.190
McDivitt R.W. & Stewart F.W. 1966. Breast carcinoma in children. JAMA. 195(5): 388-390. DOI: 10.1001/jama.1966.03100050096033. DOI: https://doi.org/10.1001/jama.1966.03100050096033
Richard G., Hawk J.C. III, Baker Jr. A.S. & Austin R.M. 1990. Multicentric adult secretory breast carcinoma: DNA flow cytometric findings, prognostic features, and review of the world literature. Journal of Surgical Oncology. 44(4): 238-244. DOI: 10.1002/jso.2930440410. DOI: https://doi.org/10.1002/jso.2930440410
Sato T., Iwasaki A., Iwama T., Kawai S., Nakagawa T. & Sugihara K. 2012. A rare case of extensive ductal carcinoma in situ of the breast with secretory features. Rare tumors. 4(4): 169-171. DOI: 10.4081/rt.2012.e52. DOI: https://doi.org/10.4081/rt.2012.e52
Sharma R., Singh S. & Jaswal T.S. 1999. Secretory carcinoma of breast in an elderly female. Indian Journal of Pathology and Microbiology. 42(1): 93-95.
Silva H., Reys M., Cassali G., Souza F., Horta R., Sena B., Bindaco A., Pinto A., Souza T. & Flecher M. 2022. Secretory carcinoma of the canine mammary gland with nodal and bone metastases: case report. Open Veterinary Journal. 12(4): 502-507. DOI: 10.5455/OVJ.2022.v12.i4.12. DOI: https://doi.org/10.5455/OVJ.2022.v12.i4.12
Strauss B.L., Bratthauer G.L. & Tavassoli F.A. 2006. STAT 5a expression in the breast is maintained in secretory carcinoma, in contrast to other histologic types. Human Pathology. 37(5): 586-592. DOI: 10.1016/j.humpath.2006.01.009. DOI: https://doi.org/10.1016/j.humpath.2006.01.009
Sullivan J.J., Magee H.R. & Donald K.J. 1977. Secretory (juvenile) carcinoma of the breast. Pathology. 9(4): 341-346. DOI: 10.3109/00313027709094454. DOI: https://doi.org/10.3109/00313027709094454
Szántó J., András C., Tsakiris J., Gomba S., Szentirmay Z., Bánlaki S., Szilágyi I., Kiss C., Antall P. & Horváth Á., Lengyel L. & Castiglione-Gertsch M. 2004. Secretory breast cancer in a 7.5-year-old boy. Breast. 13(5): 439-442. DOI: 10.1016/j.breast.2004.02.011. DOI: https://doi.org/10.1016/j.breast.2004.02.011
Tavassoli F.A. 2003. Pathology and Genetics of Tumors of the Breast and Female Genital Organs. In: Fattaneh A., Tavassoli F.A. & Devilee P. (Eds). World Health Organization Classification of Tumours. 3rd edn. Lyon: IARC Press, pp.391-397.
Tavassoli F.A. & Norris H.J. 1980. Secretory carcinoma of the breast. Cancer. 45(9): 2404-2413. DOI: 10.1002/1097-0142(19800501)45:9<2404::aid-cncr2820450928>3.0.co;2-8. DOI: https://doi.org/10.1002/1097-0142(19800501)45:9<2404::AID-CNCR2820450928>3.0.CO;2-8
Vasudev P. & Onuma K. 2011. Secretory breast carcinoma: Unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression. Archives of Pathology & Laboratory Medicine. 135(12): 1606-1610. DOI: 10.5858/arpa.2010-0351-RS. DOI: https://doi.org/10.5858/arpa.2010-0351-RS
Yang Y., Wang Z., Pan G., Li S., Wu Y. & Liu L. 2019. Pure secretory carcinoma in situ: a case report and literature review. Diagnostic Pathology. 14: 95. DOI: 10.1186/s13000-019-0872-7. DOI: https://doi.org/10.1186/s13000-019-0872-7
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Marina Possa dos Reys, Fernanda Rezende Souza, Érica Almeida Viscone, Karen Yumi Ribeiro Nakagaki, Geovanni Dantas Cassali
This work is licensed under a Creative Commons Attribution 4.0 International License.
This journal provides open access to all of its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Such access is associated with increased readership and increased citation of an author's work. For more information on this approach, see the Public Knowledge Project and Directory of Open Access Journals.
We define open access journals as journals that use a funding model that does not charge readers or their institutions for access. From the BOAI definition of "open access" we take the right of users to "read, download, copy, distribute, print, search, or link to the full texts of these articles" as mandatory for a journal to be included in the directory.
La Red y Portal Iberoamericano de Revistas Científicas de Veterinaria de Libre Acceso reúne a las principales publicaciones científicas editadas en España, Portugal, Latino América y otros países del ámbito latino
